KRAS and Nephroblastoma: Dr. Chang described eight patients with KRAS mutant mosaicism and their clinical features, which in several cases included embryonal tumors (rhabdomyosarcoma and Wilms tumor) and other less common symptoms, such as epilepsy, polycystic kidneys, T‐cell deficiency, and multifocal lytic bone lesions.